8-K - Indivior Pharmaceuticals, Inc. (0001625297) (Filer)
Filed: 2026-09-15 AccNo: 0001625297-26-000028 Size: 221 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Source
U.S. Securities and Exchange Commission · Sep 15, 2026
Read original